ABSTRACT The amino-acid sequence of Fragment A from diphtheria toxin is reported. Fragment A (molecular weight, M,, 21,145) is the major enzymically active fragment produced upon activation of the intact toxin (M, about 60,000) by limited tryp ic digestion and reduction. It, or a similar fragment, is believed responsible for the inhibition of protein synthesis in animal cells exposed to the toxin. Fragment A, which corresponds to the amino terminus of the toxin, is shown here to consist of three major forms (190, 192, and 193 residues) resulting from cleavage by trypsin adjacent to any of three closely spaced arginine residues. All three forms are enzymically active.
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Diphtheria toxin (molecular weight, Mr, about 60,000) inhibits protein synthesis in sensitive mammalian cells, and this effect is probably responsible for its toxicity for man and certain animals (1, 2) . The biochemical mechanism of the inhibition is now well understood. The toxin is a proenzyme which, after activation, catalyzes the covalent attachment of the adenosine diphosphate ribose moiety (ADP-Rib) of nicotinamide adenine dinucleotide (NAD) to elongation factor 2 (EF-2).
EF-2 + NAD ADP-Rib-EF-2 + nicotinamide + H+ This modification inactivates EF-2, thus blocking peptide chain elongation on the ribosomes (1) (2) (3) (4) .
Activation of the toxin, a single polypeptide chain (Mr about 60,000), requires proteolytic cleavage as an essential step (5, 6) . In fact, the enzymically active entities are large proteolytic fragments from the toxin. These fragments must be dissociated from the remainder of the molecule before activity is expressed. When In. addition to catalyzing the ADP-ribosylation of EF-2, Fragment A has weak NAD-glycohydrolase activity (EC 3.2.2.5), which results in the release of ADP-Rib, nicotinamide, and H+. These properties together with the interesting biological activity of the toxin have led us to determine the primary structure of the fragment.
MATERIALS AND METHODS Diphtheria Toxin. Partially purified toxin obtained from Connaught Laboratories, Toronto, Canada, was further purified by chromatography on columns of DEAE-cellulose and Sephadex G-100, as described previously (10) .
Fragment A. The purified toxin (A280 = 12.2) was incubated with trypsin (1 ug/ml) at 250 for 45 min, and digestion was terminated by adding soybean trypsin inhibitor (1.5 ,ug/ml) (5). The cleaved toxin was then reduced in the presence of 50 mM dithiothreitol and 0.5 M guanidine-HCI, and the free sulfhydryl groups were blocked by dialysis against 30 mM 2,2'-dihydroxyethyl disulfide. Fragment A was subsequently purified by chromatography on Sephadex G-100. The buffer used in all steps was 50 mM Tris-HCl, pH 8.2, containing 1 mM ethylenediaminetetraacetate. About 1.6 g of Fragment A was used for the sequence analysis.
Sequencing Methods. Four types of peptides were obtained to establish the complete sequence of Fragment A: (a) cyanogen bromide peptides, which were initially fractionated on a column of Sephadex G-50 (11); (b) tryptic peptides from the maleylated protein, which were initially separated on a column of Sephadex G-50; (c) chymotryptic peptides, which were initially fractionated on a column of Dowex 50; and (d) peptides formed by cleavage of Fragment A at the two tryptophan residues with the bromine adduct of 2-(2-nitrophenylsulfenyl)-3-methylindole (BNPS-skatole) by the procedure of Omenn et al. (12) ; these peptides were separated on a column of Sephadex G-75. The reduced Fragment A used to obtain peptides (a), (b), and (c) had been treated to form the S-carboxymethylcysteine derivative. The protein used for method (d) was in the form of the mixed disulfide of cysteine and 2-mercaptoethanol. When further purification of peptides was required, gel filtration, paper electrophoresis at pH 1.9 and 3.6, and paper chromatography were utilized. Large peptides were further hydrolyzed with trypsin, chymotrypsin, thermolysin, subtilisin, etc., to give smaller peptides which were isolated and studied. Fragment A and several of the largest peptides were subjected to automatic Edman degradation with the aid of a Beckman 860C sequenator. All other sequence methods are as previously described (13, 14) .
RESULTS
The amino-acid composition of Fragment A is given in Fig. 1 ) were isolated and extensively studied (11) . These were Peptide CNBr-1 (residues 1-14), Peptide CNBr-2 (residues 15-115), Peptide CNBr-3 (residues 116-178), Peptide CNBr-4 (residues 179-182), and Peptide CNBr-5 (residues 183-193). Two other peptides were found which proved to be the same as Peptide CNBr-5, except that one lacked the COOH-terminal arginine, and the other lacked the COOH-terminal Val-ArgArg sequence.
The presence of three distinct COOH-terminal peptides indicates that Fragment A is heterogeneous and is formed from diphtheria toxin by tryptic cleavage at any of the three arginine residues in the sequence Arg-Val-Arg-Arg (residues 190-193). The three species formed (190, 192, and 193 residues, respectively) probably correspond to the three major bands observed when Fragment A is electrophoresed in 7.5% polyacrylamide gels in the absence of detergent (7) . The presence of an additional, positively charged arginine residue in each succeedingly longer molecule could account for the electrophoretic separation of the three components. All three forms isolated from polyacrylamide gels catalyze both the ADP-ribosylation of EF-2 and the hydrolysis of NAD. They are formed in similar amounts and do not differ markedly from one another in specific activity. At least one active, minor electrophoretic form has been detected, but its chemical nature is not yet known.
Six tryptic peptides were isolated from the maleylated protein: Peptide Tm-i (residues 1-126), Peptide Tm-2 (residues 127-133), Peptide Tm-S (residues 134-170), Peptide Tm-4 (residues 171-173), Peptide Tm-5 (residues 174-190), and Peptide Tm-6 (residues 191-193). ' Determined spectrophotometrically (16) .
More than 40 chymotryptic peptides were purified from all regions of Fragment A except residues 13-17 and 160-167. In addition to the usual hydrolysis at tyrosyl, phenylalanyl, leucyl, and tryptophyl residues, there was limited scission at certain glutaminyl, histidyl, lysyl, and aspartyl residues. The last was probably due to the greater lability of aspartyl bonds in acid (15) .
Three peptides were isolated after cleavage of Fragment A with BNPS-skatole: Peptide BNPS-1 (residues 1-50), Peptide BNPS-2 (residues 51-153), and Peptide BNPS-3 (residues 154-193). The reaction proceeded in 30-40% yield, which left some Fragment A and two large, overlapping peptides (residues 1-153 and 51-193) which were not isolated in pure form.
The cleavage with BNPS-skatole facilitated location of the second tryptophan in the sequence. Analysis of tryptophan by the method of Edelhoch (16) had indicated the presence of two such residues instead of 3, as previously estimated (7). One of the tryptophans was clearly placed at residue 153, and the other one was known to be in the region of residues 40-51, but its exact location at residue 50 was established by cleavage with BNPS-skatole.
A second problem was solved with the aid of a Beckman 890C sequencer. We were often unable to detect peptides corresponding to the region around residues 160-167 either in the chymotryptic hydrolysate or in hydrolysates of Peptides CNBr-3 or Tm-3. Automatic Edman degradation of Peptide BNPS-3 with the sequencer provided the previously unknown sequence of residues 162-164 and confirmed the sequence of other residues on either side of this region.
It should be noted that the sequence of the NH2-terminal 17 residues of Fragment A is in agreement with the NH2-terminal sequence determined with a sequenator by Michel et al. (8) . We identified residue 16 as asparagine which was not identified by these investigators.
DISCUSSION
A major point of interest in the sequence is the heterogeneity at the COOH-terminus of Fragment A. The results suggest that trypsin preferentially attacks the intact toxin at any of three closely spaced arginines (residues 190, 192, and 193 ). There may be other additional basic residues COOHterminal to residue 193 which also contribute to the formation of Fragment A, but, if present, these residues are lost as peptides or remain in the NH2-terminal region of Fragment B.
The presence of a cluster of residues which are highly sensitive to proteolysis in the native protein suggests that this region may have been evolutionarily designed for cleavage. There is no direct evidence yet that the toxin is cleaved in an animal host or animal cell cultures, but this seems probable from our knowledge of the activity of the toxin in vitro. The toxin strongly inhibits protein synthesis in cell culture, and this activity is expressed in cell-free systems only by certain proteolytic fragments of the toxin, Fragment A being the smallest and most active (1, 2) .
Less well understood is the function of the toxin in the bacterial cell in which it is synthesized. The structural gene for the toxin resides on the genome of bacteriophage 1B or other similar bacteriophages, but its function in phage replication or control is unknown. Conceivably such a function would require hydrolysis (and reduction) and would aid in explaining the evolution of the toxin and its structure-activity relationships.
The roles of the various amino-acid residues in the catalytic activity of Fragment There are a few interesting features with respect to the distribution of residues in the sequence of Fragment A. All seven arginyl residues are present in the region from residue 126 to 193, with three of them present in the last four residues of the molecule (residues 190-193) . Also, the region from residue 66 to 122 contains only one aromatic residue despite an average of 13% aromatic residues in the rest of the molecule.
The molecular weight of Fragment A as calculated from the sequence data (21,145 for the isoelectric longest form) is slightly lower than that estimated by electrophoresis in polyacrylamide gels in the presence of dodecyl sulfate (24,000). Sedimentation equilibrium studies have yielded an intermediate value (22,800 L 600). The basis of these differences is unknown, but the value from the sequence data may probably be considered the most reliable.
Finally, the sequence presented may be of more widespread interest than originally believed. The notion that the ADP-ribosylation of EF-2 is an activity unique to diphtheria toxin was recently dispelled, when it was found that a protein exotoxin produced by Pseudomonas aeruginosa has the same activity (18) . We have confirmed this report.
